Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2)

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 3, Issue 3, 2015, Pages 258-264.e1

  Todd, Kenneth L ^a   Wright, David I ^b,c  

^a Southeast Vein and Laser Center   (United States)

^b BIOCOMPATIBLES UK LTD   (United Kingdom)

^c BTG International Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; POLIDOCANOL; MACROGOL DERIVATIVE; SCLEROSING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SELF EVALUATION; SYMPTOM ASSESSMENT; TREATMENT DURATION; VARICOSIS; VEIN THROMBOSIS; LOW LEVEL LASER THERAPY; MIDDLE AGED; QUESTIONNAIRE; SAPHENOUS VEIN; TREATMENT OUTCOME; VEIN INSUFFICIENCY; YOUNG ADULT;

ADULT; AGED; FEMALE; HUMANS; LASER THERAPY; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; QUALITY OF LIFE; SAPHENOUS VEIN; SCLEROSING SOLUTIONS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; VARICOSE VEINS; VENOUS INSUFFICIENCY; YOUNG ADULT;

EID: 84937191086     PISSN: 2213333X     EISSN: 22133348     Source Type: Journal    
DOI: 10.1016/j.jvsv.2015.03.003     Document Type: Article

References (17)

1. X. Jia, G. Mowatt, J. Burr, K. Cassar, J. Cook, and C. Fraser Systematic review of foam sclerotherapy for varicose veins Br J Surg 94 2007 925 936
2. J. Cabrera, J. Cabrera Jr., and M.A. Garcia-Olmedo Sclerosants in microfoam: a new approach in angiology Int Angiol 20 2001 322 329
3. J. Cabrera, J. Cabrera Jr., M.A. Garcia-Olmedo, and P. Redondo Treatment of venous malformations with sclerosant in microfoam form Arch Dermatol 139 2003 1409
4. E. Rabe, J. Otto, D. Schliephake, and F. Pannier Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial Eur J Vasc Endovasc Surg 35 2008 238 245
5. C. Hamel-Desnos, P. Desnos, J.C. Wollmann, P. Ouvry, S. Mako, and F.A. Allaert Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results Dermatol Surg 29 2003 1170.e117
6. J. Guex Complications and side-effects of foam sclerotherapy Phlebology 24 2009 270 274
7. T. Sarvananthan, A.C. Shepherd, and T. Willenberg Neurological complications of sclerotherapy for varicose veins J Vasc Surg 55 2012 243 251
8. K. Parsi Paradoxical embolism, stroke and sclerotherapy Phlebology 27 2012 147 167
9. R.G. Bush, M. Derrick, and D. Manjoney Major neurological events following foam sclerotherapy Phlebology 23 2008 189 192
10. M.V. Forlee, M. Grouden, D.J. Moore, and G. Shanik Stroke after varicose vein foam injection sclerotherapy J Vasc Surg 43 2006 162 164
11. C.B. Asbjorgsen, C.D. Rogers, and B.L. Russell Middle cerebral air embolism after foam sclerotherapy Phlebology 27 2012 430 433
12. U.S. Department of Health and Human Services, Food and Drug Administration Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims December 2009 Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf Accessed September 15, 2014
13. K.L. Todd 3rd, D. Wright the VANISH-2 Investigator Group The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence Phlebology 29 2014 608 618
14. J.T. Christenson, S. Gueddi, G. Gemayel, and H. Bounameaux Prospective randomized trial comparing endovenous laser ablation and surgery for treatment of primary great saphenous varicose veins with a 2-year followup J Vasc Surg 52 2010 1234 1241
15. R.A. Weiss, and M.A. Weiss Controlled radiofrequency endovenous occlusion using a unique radiofrequency catheter under duplex guidance to eliminate saphenous varicose vein reflux: a 2-year follow-up Dermatol Surg 28 2002 38 42
16. N.S. Theivacumar, R. Darwood, and M.J. Gough Neovascularisation and recurrence 2 years after varicose vein treatment for sapheno-femoral and great saphenous vein reflux: a comparison of surgery and endovenous laser ablation Eur J Vasc Endovasc Surg 38 2009 203 207
17. L.H. Rasmussen, M. Lawaetz, L. Bjoern, B. Vennits, A. Blemings, and B. Eklof Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins Br J Surg 98 2011 1079 1087